Longboard Pharmaceuticals Ownership 2024 | Who Owns Longboard Pharmaceuticals Now?
Institutional Ownership
99.80%
Insider Ownership
1.31%
Retail Ownership
-1.11%
Institutional Holders
101.00
Longboard Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 11.36% | 0.01% | 4,415,218 | -109,852 | -2.43% | 119,343,342 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 8.46% | 1.18% | 3,289,119 | - | - | 88,904,887 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 7.56% | 0.38% | 2,940,500 | - | - | 79,481,715 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 7.18% | 4.36% | 2,790,462 | -562,679 | -16.78% | 75,426,188 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.45% | 0.01% | 2,508,536 | 290,541 | 13.10% | 67,807,000 | Jun 30, 2024 |
| BLACKROCK INC. | 6.09% | 0.00% | 2,368,451 | 502,161 | 26.91% | 64,019,232 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.95% | 0.00% | 1,925,147 | 200,716 | 11.64% | 52,036,723 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 4.58% | 0.01% | 1,778,971 | -357,392 | -16.73% | 48,085,586 | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | 4.27% | 0.17% | 1,658,962 | 677,634 | 69.05% | 44,841,743 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 3.48% | 0.22% | 1,354,505 | 49,074 | 3.76% | 36,612,270 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 2.83% | 2.82% | 1,100,000 | 125,000 | 12.82% | 29,733,000 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 2.65% | 0.07% | 1,031,371 | -343,629 | -24.99% | 27,877,958 | Jun 30, 2024 |
| JENNISON ASSOCIATES LLC | 2.45% | 0.02% | 951,968 | 9,564 | 1.01% | 25,731,695 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 2.35% | 0.03% | 913,782 | 337,106 | 58.46% | 24,699,527 | Jun 30, 2024 |
| STATE STREET CORP | 2.06% | 0.00% | 801,852 | 153,343 | 23.65% | 21,674,060,000 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 1.79% | 2.51% | 694,178 | 1,034 | 0.15% | 18,763,631 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.76% | 0.00% | 682,391 | 126,308 | 22.71% | 18,448,629 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 1.56% | 0.00% | 606,595 | 101,421 | 20.08% | 16,396,262 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.26% | 0.13% | 488,793 | 100,321 | 25.82% | 13,212,075 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 1.23% | 0.01% | 476,390 | 196,464 | 70.18% | 12,876,837 | Jun 30, 2024 |
Longboard Pharmaceuticals's largest institutional shareholder is FMR LLC, holding 11.36% of the company's total share outstanding, currently valued at $119.34M. The top 10 institutional shareholders own together 64.38% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | 7.18% | 4.36% | 2,790,462 | -562,679 | -16.78% | 75,426,188 | Jun 30, 2024 |
| NAN FUNG GROUP HOLDINGS LTD | 0.37% | 4.17% | 144,570 | 26,315 | 22.25% | 3,907,727 | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | 0.56% | 3.53% | 218,981 | -51,578 | -19.06% | 5,919,056 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 2.83% | 2.82% | 1,100,000 | 125,000 | 12.82% | 29,733,000 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 1.79% | 2.51% | 694,178 | 1,034 | 0.15% | 18,763,631 | Jun 30, 2024 |
| LYNX1 CAPITAL MANAGEMENT LP | 0.43% | 1.64% | 167,317 | 167,317 | 100.00% | 4,522,579 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 8.46% | 1.18% | 3,289,119 | - | - | 88,904,887 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.32% | 0.78% | 122,849 | 122,849 | 100.00% | 3,320,608 | Jun 30, 2024 |
| SATURN V CAPITAL MANAGEMENT LLC | 0.18% | 0.73% | 71,442 | 71,442 | 100.00% | 1,931,077 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 7.56% | 0.38% | 2,940,500 | - | - | 79,481,715 | Jun 30, 2024 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 0.47% | 0.26% | 183,577 | 183,577 | 100.00% | 4,962,086 | Jun 30, 2024 |
| EMERALD ADVISERS, LLC | 0.59% | 0.26% | 228,523 | 228,523 | 100.00% | 6,176,980 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 3.48% | 0.22% | 1,354,505 | 49,074 | 3.76% | 36,612,270 | Jun 30, 2024 |
| BRAIDWELL LP | 0.53% | 0.17% | 205,926 | 205,926 | 100.00% | 5,566,180 | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | 4.27% | 0.17% | 1,658,962 | 677,634 | 69.05% | 44,841,743 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.26% | 0.13% | 488,793 | 100,321 | 25.82% | 13,212,075 | Jun 30, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 0.29% | 0.12% | 114,047 | -13,001 | -10.23% | 3,082,690 | Jun 30, 2024 |
| EAM INVESTORS, LLC | 0.07% | 0.11% | 25,530 | -131,035 | -83.69% | 690,076 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.13% | 0.09% | 51,596 | -2,457 | -4.55% | 1,394,640 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 2.65% | 0.07% | 1,031,371 | -343,629 | -24.99% | 27,877,958 | Jun 30, 2024 |
The largest Longboard Pharmaceuticals shareholder by % of total assets is CORMORANT ASSET MANAGEMENT, LP. The company owns 2.79M shares of Longboard Pharmaceuticals (LBPH), representing 4.36% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 4.27% | 0.17% | 1,658,962 | 677,634 | 69.05% | 44,841,743 | Jun 30, 2024 |
| BLACKROCK INC. | 6.09% | 0.00% | 2,368,451 | 502,161 | 26.91% | 64,019,232 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 2.35% | 0.03% | 913,782 | 337,106 | 58.46% | 24,699,527 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.45% | 0.01% | 2,508,536 | 290,541 | 13.10% | 67,807,000 | Jun 30, 2024 |
| EMERALD ADVISERS, LLC | 0.59% | 0.26% | 228,523 | 228,523 | 100.00% | 6,176,980 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 0.58% | 0.04% | 225,917 | 225,917 | 100.00% | 6,106,252 | Jun 30, 2024 |
| BRAIDWELL LP | 0.53% | 0.17% | 205,926 | 205,926 | 100.00% | 5,566,180 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.95% | 0.00% | 1,925,147 | 200,716 | 11.64% | 52,036,723 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 1.23% | 0.01% | 476,390 | 196,464 | 70.18% | 12,876,837 | Jun 30, 2024 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 0.47% | 0.26% | 183,577 | 183,577 | 100.00% | 4,962,086 | Jun 30, 2024 |
| LYNX1 CAPITAL MANAGEMENT LP | 0.43% | 1.64% | 167,317 | 167,317 | 100.00% | 4,522,579 | Jun 30, 2024 |
| STATE STREET CORP | 2.06% | 0.00% | 801,852 | 153,343 | 23.65% | 21,674,060,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.76% | 0.00% | 682,391 | 126,308 | 22.71% | 18,448,629 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 2.83% | 2.82% | 1,100,000 | 125,000 | 12.82% | 29,733,000 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.32% | 0.78% | 122,849 | 122,849 | 100.00% | 3,320,608 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 1.56% | 0.00% | 606,595 | 101,421 | 20.08% | 16,396,262 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.26% | 0.13% | 488,793 | 100,321 | 25.82% | 13,212,075 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.23% | 0.00% | 90,154 | 81,801 | 979.30% | 2,436,863 | Jun 30, 2024 |
| SATURN V CAPITAL MANAGEMENT LLC | 0.18% | 0.73% | 71,442 | 71,442 | 100.00% | 1,931,077 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.13% | 0.00% | 50,056 | 50,056 | 100.00% | 1,353,014 | Jun 30, 2024 |
As of Jun 30 2024, Longboard Pharmaceuticals's largest institutional buyer is VIKING GLOBAL INVESTORS LP. The company purchased 677.63K stocks of LBPH, valued at $44.84M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | 7.18% | 4.36% | 2,790,462 | -562,679 | -16.78% | 75,426,188 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.44% | 0.00% | 169,843 | -363,192 | -68.14% | 4,590,856 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 4.58% | 0.01% | 1,778,971 | -357,392 | -16.73% | 48,085,586 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 2.65% | 0.07% | 1,031,371 | -343,629 | -24.99% | 27,877,958 | Jun 30, 2024 |
| AWM INVESTMENT COMPANY, INC. | - | - | - | -211,518 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -198,310 | -100.00% | - | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | - | - | - | -170,000 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.84% | 0.00% | 324,943 | -154,866 | -32.28% | 8,783,209 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.25% | 0.02% | 96,325 | -136,645 | -58.65% | 2,603,664 | Jun 30, 2024 |
| EAM INVESTORS, LLC | 0.07% | 0.11% | 25,530 | -131,035 | -83.69% | 690,076 | Jun 30, 2024 |
| FMR LLC | 11.36% | 0.01% | 4,415,218 | -109,852 | -2.43% | 119,343,342 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 1.19% | 0.02% | 462,623 | -103,875 | -18.34% | 12,504,700 | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| J. GOLDMAN & CO LP | 0.07% | 0.02% | 25,669 | -89,811 | -77.77% | 693,833 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -71,400 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.13% | 0.00% | 50,300 | -56,585 | -52.94% | 1,359,609 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -55,137 | -100.00% | - | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | 0.56% | 3.53% | 218,981 | -51,578 | -19.06% | 5,919,056 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.05% | 0.01% | 20,000 | -50,000 | -71.43% | 540,600 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | - | - | - | -25,501 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Longboard Pharmaceuticals's biggest institutional seller is CORMORANT ASSET MANAGEMENT, LP. The company sold -0.56M shares of LBPH, valued at $75.43M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| EMERALD ADVISERS, LLC | 0.59% | 0.26% | 228,523 | 228,523 | 100.00% | 6,176,980 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 0.58% | 0.04% | 225,917 | 225,917 | 100.00% | 6,106,252 | Jun 30, 2024 |
| BRAIDWELL LP | 0.53% | 0.17% | 205,926 | 205,926 | 100.00% | 5,566,180 | Jun 30, 2024 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 0.47% | 0.26% | 183,577 | 183,577 | 100.00% | 4,962,086 | Jun 30, 2024 |
| LYNX1 CAPITAL MANAGEMENT LP | 0.43% | 1.64% | 167,317 | 167,317 | 100.00% | 4,522,579 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.32% | 0.78% | 122,849 | 122,849 | 100.00% | 3,320,608 | Jun 30, 2024 |
| SATURN V CAPITAL MANAGEMENT LLC | 0.18% | 0.73% | 71,442 | 71,442 | 100.00% | 1,931,077 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.13% | 0.00% | 50,056 | 50,056 | 100.00% | 1,353,014 | Jun 30, 2024 |
| ALPS ADVISORS INC | 0.07% | 0.00% | 26,239 | 26,239 | 100.00% | 709,240 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.05% | 0.03% | 21,242 | 21,242 | 100.00% | 574,171 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.05% | 0.00% | 20,000 | 20,000 | 100.00% | 540,600 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 17,400 | 17,400 | 100.00% | 470,322 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.03% | 0.00% | 13,016 | 13,016 | 100.00% | 351,822 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 0.03% | 0.00% | 12,300 | 12,300 | 100.00% | 332,285 | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0.02% | 0.00% | 9,015 | 9,015 | 100.00% | 243,675 | Jun 30, 2024 |
| ARIZONA STATE RETIREMENT SYSTEM | 0.02% | 0.00% | 7,994 | 7,994 | 100.00% | 216,078 | Jun 30, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | 0.02% | 0.00% | 7,700 | 7,700 | 100.00% | 208,131 | Jun 30, 2024 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 0.01% | 0.00% | 4,716 | 4,716 | 100.00% | 127,473,000 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.01% | 0.06% | 4,538 | 4,538 | 100.00% | 122,662 | Jun 30, 2024 |
Longboard Pharmaceuticals's largest new institutional shareholder by number of shares is EMERALD ADVISERS, LLC, purchased 228.52K shares, valued at $6.18M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AWM INVESTMENT COMPANY, INC. | - | - | - | -211,518 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -198,310 | -100.00% | - | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | - | - | - | -170,000 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -71,400 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -55,137 | -100.00% | - | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | - | - | - | -25,501 | -100.00% | - | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -23,853 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -22,949 | -100.00% | - | Jun 30, 2024 |
| SEI INVESTMENTS CO | - | - | - | -19,861 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -19,110 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -12,283 | -100.00% | - | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -9,624 | -100.00% | - | Jun 30, 2024 |
| DENALI ADVISORS LLC | - | - | - | -9,300 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -6,102 | -100.00% | - | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -4,580 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -1,689 | -100.00% | - | Jun 30, 2024 |
| POINT72 (DIFC) LTD | - | - | - | -1,569 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,358 | -100.00% | - | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | - | - | - | -236 | -100.00% | - | Jun 30, 2024 |
| LIFESTEPS FINANCIAL, INC. | - | - | - | -200 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -2 | -100.00% | - | Jun 30, 2024 |
Longboard Pharmaceuticals's largest sold out institutional shareholder by shares sold is AWM INVESTMENT COMPANY, INC., sold -0.21M shares, valued at -, as of undefined.
Longboard Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. | 0.25% | 839,317 | 294,366 | 54.02% | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.17% | 872,701 | 109,505 | 14.35% | Mar 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.16% | 338,184 | 338,184 | - | Feb 29, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.04% | 339,270 | -232,257 | -40.64% | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.03% | 70,000 | - | - | Mar 28, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.03% | 1,778,489 | 1,229,175 | 223.77% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.03% | 214,700 | 214,700 | - | Mar 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.03% | 123,072 | 123,072 | - | Jan 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.03% | 41,644 | 15,863 | 61.53% | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.03% | 13,099 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.02% | 229,738 | 229,738 | - | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.01% | 165,700 | 165,700 | - | Jan 31, 2024 |
| BlackRock Health Sciences Trust | 0.01% | 2,931 | 2,931 | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.01% | 28,227 | 28,227 | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 43,681 | 19,324 | 79.34% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,599 | 1,169 | 48.11% | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,480,763 | 583,160 | 64.97% | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 321,600 | 101,486 | 46.11% | Jan 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 25,026 | 25,026 | - | Mar 28, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 71,903 | 71,903 | - | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 3,299 | 3,299 | - | Feb 29, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 5,700 | 5,700 | - | Mar 28, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 244,122 | 83,922 | 52.39% | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 46,773 | 3,840 | 8.94% | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,486 | 1,200 | 93.31% | Mar 31, 2024 |
| Voya INVESTORS TRUST | 0.00% | 44,379 | -4,342 | -8.91% | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 3,045 | - | - | Mar 28, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 3,147 | 3,147 | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 20,983 | 4,797 | 29.64% | Mar 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 14,793 | -909 | -5.79% | Mar 31, 2024 |
| ProFunds | 0.00% | 6,334 | 6,204 | 4772.31% | Mar 31, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 35,800 | 35,800 | - | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 7,696 | 6,929 | 903.39% | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 7,716 | 1,244 | 19.22% | Mar 31, 2024 |
| Guardian Variable Products Trust | 0.00% | 3,900 | 3,900 | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 43,300 | 43,300 | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,101 | 558 | 102.76% | Mar 31, 2024 |
| Global X Funds | 0.00% | 9,578 | - | - | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 12,995 | 12,995 | - | Feb 29, 2024 |
| JPMorgan Trust I | 0.00% | 202,251 | - | - | Jan 31, 2024 |
| RBB FUND, INC. | 0.00% | 14,027 | 14,027 | - | Feb 29, 2024 |
| AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC | 0.00% | 2,011 | 2,011 | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 9,200 | 4,400 | 91.67% | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 349 | - | - | Mar 31, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.00% | 15,939 | 15,939 | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.00% | 2,793 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 110,986 | 74,748 | 206.27% | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 11,535 | 9,377 | 434.52% | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 11,057 | 4,339 | 64.59% | Mar 28, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 27,637 | 27,637 | - | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 7,420 | 2,402 | 47.87% | Feb 29, 2024 |
| BlackRock ETF Trust | 0.00% | 58 | 58 | - | Jan 31, 2024 |
| iSHARES TRUST | 0.00% | 929,664 | 364,946 | 64.62% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 68,423 | 8,046 | 13.33% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 142 | - | - | Dec 31, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 32,698 | 32,698 | - | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 27,217 | 21,536 | 379.09% | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 62,731 | 50,360 | 407.08% | Mar 31, 2024 |
| HARTFORD MUTUAL FUNDS INC/CT | 0.00% | 193,590 | 193,590 | - | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 1,371 | - | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 5,978 | -24 | -0.40% | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 600 | - | - | Mar 28, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 48,044 | -4,332 | -8.27% | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 2,507 | - | - | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 70 | - | - | Dec 31, 2023 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 17,304 | -3,513 | -16.88% | Jan 31, 2024 |
| MAINSTAY FUNDS TRUST | 0.00% | 3,328 | 3,328 | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 5,660 | 3,929 | 226.98% | Jan 31, 2024 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 3,860 | 3,860 | - | Feb 29, 2024 |
| EMPOWER FUNDS, INC. | 0.00% | 11,793 | 11,793 | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 2,282 | 274 | 13.65% | Feb 29, 2024 |
| Columbia Funds Series Trust II | 0.00% | 2,999 | 2,999 | - | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 9 | - | - | Dec 31, 2023 |
| Brighthouse Funds Trust I | 0.00% | 59,800 | 59,800 | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 21,463 | - | - | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 689 | - | - | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 40,431 | 40,215 | 18618.06% | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 1,765 | -7 | -0.40% | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 1,084 | -961 | -46.99% | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 16,415 | 6,529 | 66.04% | Mar 31, 2024 |
| SPDR SERIES TRUST | 0.00% | 124,654 | 124,654 | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 11,421 | 6,004 | 110.84% | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 3,060 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 8,176 | 3,737 | 84.19% | Mar 31, 2024 |
| John Hancock Funds II | 0.00% | 17,782 | 5,151 | 40.78% | Feb 29, 2024 |
| T. Rowe Price Multi-Strategy Total Return Fund, Inc. | 0.00% | 134 | 134 | - | Jan 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 15,109 | 15,109 | - | Feb 29, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 3,000 | 1,199 | 66.57% | Mar 31, 2024 |
| GMO TRUST | 0.00% | 838 | 838 | - | Feb 29, 2024 |
Longboard Pharmaceuticals's largest mutual fund holder by % of total assets is "T. Rowe Price Health Sciences Fund, Inc.", owning 839.32K shares, compromising 0.25% of its total assets.
Longboard Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 101 | -6.48% |
| 31 Mar, 24 | 108 | 107.69% |
| 31 Dec, 23 | 52 | 1.96% |
| 30 Sep, 23 | 51 | 2.00% |
| 30 Jun, 23 | 50 | 100.00% |
| 31 Mar, 23 | 25 | 38.89% |
| 31 Dec, 22 | 18 | 12.50% |
| 30 Sep, 22 | 16 | -5.88% |
| 30 Jun, 22 | 17 | -10.53% |
| 31 Mar, 22 | 19 | - |
| 31 Dec, 21 | 19 | - |
| 30 Sep, 21 | 19 | 26.67% |
| 30 Jun, 21 | 15 | -31.82% |
| 31 Mar, 21 | 22 | - |
As of 30 Jun 24, 101 institutions are holding Longboard Pharmaceuticals's shares, representing a decrease of -6.48% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 38,802,383 | 2.38% |
| 31 Mar, 24 | 37,901,255 | 129.32% |
| 31 Dec, 23 | 16,527,897 | 5.54% |
| 30 Sep, 23 | 15,660,436 | 7.73% |
| 30 Jun, 23 | 14,536,384 | 10.21% |
| 31 Mar, 23 | 13,190,232 | 81.35% |
| 31 Dec, 22 | 7,273,280 | 0.18% |
| 30 Sep, 22 | 7,260,149 | -3.71% |
| 30 Jun, 22 | 7,539,610 | -0.99% |
| 31 Mar, 22 | 7,614,710 | -2.15% |
| 31 Dec, 21 | 7,782,202 | 1.45% |
| 30 Sep, 21 | 7,670,788 | -3.83% |
| 30 Jun, 21 | 7,976,370 | -10.41% |
| 31 Mar, 21 | 8,903,335 | - |
Longboard Pharmaceuticals (LBPH) has 38.80M shares outstanding as of 30 Jun 24, up 2.38% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 99.80% | 0.87% |
| 31 Mar, 24 | 107.30% | 2.25% |
| 31 Dec, 23 | 69.08% | 1.55% |
| 30 Sep, 23 | 66.68% | 1.66% |
| 30 Jun, 23 | 63.29% | 1.52% |
| 31 Mar, 23 | 64.63% | 3.62% |
| 31 Dec, 22 | 42.26% | 2.36% |
| 30 Sep, 22 | 42.27% | 2.18% |
| 30 Jun, 22 | 44.01% | 2.22% |
| 31 Mar, 22 | 44.57% | 2.13% |
| 31 Dec, 21 | 45.71% | 2.21% |
| 30 Sep, 21 | 45.48% | 2.02% |
| 30 Jun, 21 | 47.40% | 1.87% |
| 31 Mar, 21 | 50.40% | - |
As of 30 Jun 24, Longboard Pharmaceuticals is held by 99.80% institutional shareholders, representing a 0.87% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 67 | -27.96% |
| 31 Mar, 24 | 93 | 210.00% |
| 31 Dec, 23 | 30 | 25.00% |
| 30 Sep, 23 | 24 | -41.46% |
| 30 Jun, 23 | 41 | 86.36% |
| 31 Mar, 23 | 22 | 120.00% |
| 31 Dec, 22 | 10 | 150.00% |
| 30 Sep, 22 | 4 | - |
| 30 Jun, 22 | 4 | -20.00% |
| 31 Mar, 22 | 5 | -16.67% |
| 31 Dec, 21 | 6 | -33.33% |
| 30 Sep, 21 | 9 | 50.00% |
| 30 Jun, 21 | 6 | -72.73% |
| 31 Mar, 21 | 22 | - |
67 institutional shareholders have increased their position in LBPH stock as of 30 Jun 24 compared to 93 in the previous quarter (a -27.96% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 28 | 250.00% |
| 31 Mar, 24 | 8 | -20.00% |
| 31 Dec, 23 | 10 | -28.57% |
| 30 Sep, 23 | 14 | 133.33% |
| 30 Jun, 23 | 6 | 200.00% |
| 31 Mar, 23 | 2 | -50.00% |
| 31 Dec, 22 | 4 | -42.86% |
| 30 Sep, 22 | 7 | - |
| 30 Jun, 22 | 7 | 40.00% |
| 31 Mar, 22 | 5 | 25.00% |
| 31 Dec, 21 | 4 | -33.33% |
| 30 Sep, 21 | 6 | - |
| 30 Jun, 21 | 6 | - |
| 31 Mar, 21 | - | - |
28 institutional shareholders have reduced their position in LBPH stock as of 30 Jun 24 compared to 8 in the previous quarter (a 250.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 101 | -6.48% | 38,802,383 | 2.38% | 99.80% | 0.87% | 67 | -27.96% | 28 | 250.00% |
| 31 Mar, 24 | 108 | 107.69% | 37,901,255 | 129.32% | 107.30% | 2.25% | 93 | 210.00% | 8 | -20.00% |
| 31 Dec, 23 | 52 | 1.96% | 16,527,897 | 5.54% | 69.08% | 1.55% | 30 | 25.00% | 10 | -28.57% |
| 30 Sep, 23 | 51 | 2.00% | 15,660,436 | 7.73% | 66.68% | 1.66% | 24 | -41.46% | 14 | 133.33% |
| 30 Jun, 23 | 50 | 100.00% | 14,536,384 | 10.21% | 63.29% | 1.52% | 41 | 86.36% | 6 | 200.00% |
| 31 Mar, 23 | 25 | 38.89% | 13,190,232 | 81.35% | 64.63% | 3.62% | 22 | 120.00% | 2 | -50.00% |
| 31 Dec, 22 | 18 | 12.50% | 7,273,280 | 0.18% | 42.26% | 2.36% | 10 | 150.00% | 4 | -42.86% |
| 30 Sep, 22 | 16 | -5.88% | 7,260,149 | -3.71% | 42.27% | 2.18% | 4 | - | 7 | - |
| 30 Jun, 22 | 17 | -10.53% | 7,539,610 | -0.99% | 44.01% | 2.22% | 4 | -20.00% | 7 | 40.00% |
| 31 Mar, 22 | 19 | - | 7,614,710 | -2.15% | 44.57% | 2.13% | 5 | -16.67% | 5 | 25.00% |
| 31 Dec, 21 | 19 | - | 7,782,202 | 1.45% | 45.71% | 2.21% | 6 | -33.33% | 4 | -33.33% |
| 30 Sep, 21 | 19 | 26.67% | 7,670,788 | -3.83% | 45.48% | 2.02% | 9 | 50.00% | 6 | - |
| 30 Jun, 21 | 15 | -31.82% | 7,976,370 | -10.41% | 47.40% | 1.87% | 6 | -72.73% | 6 | - |
| 31 Mar, 21 | 22 | - | 8,903,335 | - | 50.40% | - | 22 | - | - | - |
Longboard Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Longboard Pharmaceuticals's stock was made by Lind Kevin Robert on Aug 13 2024, selling 80,265 shares at $3.12 per share (valued at $250.68K). The last insider buy of LBPH was made by Kaye Randall on Aug 13 2024, buying 100 shares at $24.82 per share (worth $2.48K).
Longboard Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 3 | 5 | 60.00% |
| Q2 2024 | 5 | 1 | 500.00% |
| Q1 2024 | 6 | 1 | 600.00% |
| Q2 2023 | 6 | - | - |
| Q1 2023 | 3 | - | - |
| Q2 2022 | 11 | - | - |
| Q1 2022 | 4 | - | - |
| Q4 2021 | 2 | - | - |
| Q3 2021 | 2 | - | - |
| Q1 2021 | 5 | 9 | 55.56% |
3 total buy trades, and 5 total sell trades (buy/sell ratio of 0.60%) were made by Longboard Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 2 | - |
| Q2 2024 | - | 1 | - |
| Q1 2024 | 1 | 1 | 100.00% |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q1 2021 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of Longboard Pharmaceuticals's stocks.
Longboard Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| CYT | Cyteir Therapeutics, Inc. |
| NUVB | Nuvation Bio Inc. |
| DBTX | Decibel Therapeutics, Inc. |
| NXTC | NextCure, Inc. |
| IKNA | Ikena Oncology, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| SNSE | Sensei Biotherapeutics, Inc. |
| CSBR | Champions Oncology, Inc. |
| GRPH | LENZ Therapeutics, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| ASMB | Assembly Biosciences, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| MNOV | MediciNova, Inc. |
| DSGN | Design Therapeutics, Inc. |
| HOWL | Werewolf Therapeutics, Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| MOLN | Molecular Partners AG |
| CELC | Celcuity Inc. |
| MACK | Merrimack Pharmaceuticals, Inc. |
| TIL | Instil Bio, Inc. |
LBPH Ownership FAQ
Who Owns Longboard Pharmaceuticals?
Longboard Pharmaceuticals is owned by institutional shareholders (99.80%), insiders (1.31%), and public (-1.11%). The largest institutional shareholder of Longboard Pharmaceuticals is FMR LLC (11.36% of total shares) and the top mutual fund owner is T. Rowe Price Health Sciences Fund, Inc. (0.25% of total shares).
Who are the major institutional shareholders of Longboard Pharmaceuticals?
Longboard Pharmaceuticals's major institutional shareholders are FMR LLC, RA CAPITAL MANAGEMENT, L.P., FARALLON CAPITAL MANAGEMENT LLC, CORMORANT ASSET MANAGEMENT, LP, and PRICE T ROWE ASSOCIATES INC /MD/. The top five shareholders own together 41.01% of the company's share outstanding.
How many Longboard Pharmaceuticals shareholders are there?
As of Jun 2024, there are 101 institutional shareholders of Longboard Pharmaceuticals.
What percentage of Longboard Pharmaceuticals is owned by FMR LLC?
FMR LLC owns 4.42M shares of Longboard Pharmaceuticals, representing 11.36% of the company's total shares outstanding, valued at $119.34M (as of Jun 2024).
What percentage of Longboard Pharmaceuticals is owned by RA CAPITAL MANAGEMENT, L.P?
As of Jun 2024, RA CAPITAL MANAGEMENT, L.P holds 3.29M shares of Longboard Pharmaceuticals (LBPH), compromising 8.46% of the company, valued at $88.9M.
What percentage of Longboard Pharmaceuticals is owned by FARALLON CAPITAL MANAGEMENT LLC?
FARALLON CAPITAL MANAGEMENT LLC is the third largest holder of Longboard Pharmaceuticals. The company owns 2.94M of the company's shares outstanding (worth $79.48M).